beta

ALBO

Albireo Pharma Inc.

Albo

Chart

Stats

Earnings

News

Splits

Dividends

Earnings

Actual EPS
Consensus EPS
Estimated EPS
Number of Estimates
EPS Surprise

Stats

Summary

Albireo Pharma Inc is a development-stage pharmaceutical company. It engages in the research and development of the drug reformulation technology. The company is engaged in the development an oral insulin to treat diabetes.

Market Cap: 303 Million

Primary Exchange: NASDAQ Capital Market

Website: http://www.albireopharma.com

Shares Outstanding: 8.9 Million

Float: 5.03 Million

Dividend: 0.0 (0.0%)

Beta: 1.629453

Sector: Healthcare

Industry: Biotechnology

Short Interest (Jan 12, 2018): 31.6 Thousand

Ethical Flags

Animal testing

Longest drawdown: 2072 trading days

From: 2013-08-02 To: 2019-10-11

Lowest Point:

Ex-Date Payment Date Record Date Declared Date Amount Flag Dividend Type Qualified Indicated
Ex-Date Declared Date Record Date Payment Date Ratio To Factor For Factor
2016-11-04 30.0 1.0 30.0
Data provided by IEX Cloud